AQR Capital Management
LRMR icon

AQR Capital Management’s Larimar Therapeutics LRMR Stock Holding History

AQR Capital Management’s Portfolio LRMR Stock Details LRMR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$3.68M Buy
817,517
+315,266
+63% +$1.26M ﹤0.01% 1943
2025
Q4 		$1.91M Sell
502,251
-60,152
-11% -$234K ﹤0.01% 2149
2025
Q3 		$1.82M Buy
562,403
+133,915
+31% +$502K ﹤0.01% 2030
2025
Q2 		$1.24M Buy
428,488
+316,262
+282% +$732K ﹤0.01% 2073
2025
Q1 		$241K Buy
+112,226
New +$355K ﹤0.01% 2790
2024
Q4 		– Sell
-15,712
Closed -$103K – 2910
2024
Q3 		$103K Buy
15,712
+86
+0.6% +$691 ﹤0.01% 2654
2024
Q2 		$113K Buy
+15,626
New +$120K ﹤0.01% 2486
2019
Q3 		– Sell
-1,640
Closed -$23K – 2138
2019
Q2 		$23K Sell
1,640
-2,185
-57% -$58.2K ﹤0.01% 2055
2019
Q1 		$126K Sell
3,825
-1,748
-31% -$89.6K ﹤0.01% 2122
2018
Q4 		$331K Buy
5,573
+2,144
+63% +$212K ﹤0.01% 1937
2018
Q3 		$481K Buy
3,429
+2,099
+158% +$255K ﹤0.01% 1969
2018
Q2 		$163K Buy
+1,330
New +$113K ﹤0.01% 2251
2017
Q1 		– Sell
-3,579
Closed -$137K – 2223
2016
Q4 		$137K Sell
3,579
-7,296
-67% -$296K ﹤0.01% 2193
2016
Q3 		$432K Buy
+10,875
New +$494K ﹤0.01% 1988
2016
Q1 		– Sell
-3,575
Closed -$269K – 2257
2015
Q4 		$269K Sell
3,575
-1,563
-30% -$251K ﹤0.01% 2061
2015
Q3 		$1.97M Buy
+5,138
New +$2.32M ﹤0.01% 1134

Other funds holding LRMR

DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
BOCH
Blue Owl Capital Holdings New York $372M AUM 78.25% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
DCM
DAFNA Capital Management Los Angeles, California $440M AUM 109.12% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return

AQR Capital Management's LRMR Position: Q1 2026 in Review

AQR Capital Management increased its Larimar Therapeutics (LRMR) stake by 63% in Q1 2026, buying an estimated $1.26M and bringing the position to 817,517 shares worth $3.68M. The position accounts for ﹤0.01% of the portfolio, ranked #1943.

AQR Capital Management first reported a position in LRMR in Q3 2015 and has held it in 16 quarters since. 162 funds tracked by Wall St. Rank hold LRMR as of Q1 2026.

  • AQR Capital Management held 817,517 shares of Larimar Therapeutics worth $3.68M as of Q1 2026.
  • AQR Capital Management bought 315,266 Larimar Therapeutics shares in Q1 2026, an estimated $1.26M.
  • Larimar Therapeutics made up ﹤0.01% of AQR Capital Management's portfolio in Q1 2026, its #1943 holding.
  • AQR Capital Management first reported a position in Larimar Therapeutics in Q3 2015 and has held it in 16 quarters since.
  • 162 funds tracked by Wall St. Rank held Larimar Therapeutics as of Q1 2026.

Based on AQR Capital Management's 13F filing for Q1 2026, filed 15 May 2026.